Previous Article | Next Article 
Journal of Bacteriology, September 2000, p. 5153-5166, Vol. 182, No. 18
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
ZipA-Induced Bundling of FtsZ Polymers Mediated by
an Interaction between C-Terminal Domains
Cynthia A.
Hale,
Amy C.
Rhee, and
Piet A. J.
de Boer*
Department of Molecular Biology and
Microbiology, Case Western Reserve University School of Medicine,
Cleveland, Ohio 44106-4960
Received 28 March 2000/Accepted 23 June 2000
 |
ABSTRACT |
FtsZ and ZipA are essential components of the septal ring
apparatus, which mediates cell division in Escherichia
coli. FtsZ is a cytoplasmic tubulin-like GTPase that forms
protofilament-like homopolymers in vitro. In the cell, the protein
assembles into a ring structure at the prospective division site early
in the division cycle, and this marks the first recognized event in the assembly of the septal ring. ZipA is an inner membrane protein which is
recruited to the nascent septal ring at a very early stage through a
direct interaction with FtsZ. Using affinity blotting and protein
localization techniques, we have determined which domain on each
protein is both sufficient and required for the interaction between the
two proteins in vitro as well as in vivo. The results show that ZipA
binds to residues confined to the 20 C-terminal amino acids of FtsZ.
The FtsZ binding (FZB) domain of ZipA is significantly larger and
encompasses the C-terminal 143 residues of ZipA. Significantly, we find
that the FZB domain of ZipA is also required and sufficient to induce
dramatic bundling of FtsZ protofilaments in vitro. Consistent with the
notion that the ability to bind and bundle FtsZ polymers is essential
to the function of ZipA, we find that ZipA derivatives lacking an
intact FZB domain fail to support cell division in cells depleted for the native protein. Interestingly, ZipA derivatives which do contain an
intact FZB domain but which lack the N-terminal membrane anchor or in
which this anchor is replaced with the heterologous anchor of the DjlA
protein also fail to rescue ZipA
cells. Thus, in addition
to the C-terminal FZB domain, the N-terminal domain of ZipA is required
for ZipA function. Furthermore, the essential properties of the N
domain may be more specific than merely acting as a membrane anchor.
 |
INTRODUCTION |
The first recognized event in
bacterial cell division is assembly of the key division protein FtsZ
into a ring (the Z-ring) which spans the circumference of the cell and
resides just underneath the cytoplasmic membrane. Other division
proteins are then recruited to the Z-ring, forming the septal ring
organelle, which mediates cell wall invagination (for recent reviews,
see references 19 and 32). The
biochemical properties and tertiary structure (15, 25, 26)
of FtsZ reveal that the protein shares many features with eukaryotic
tubulins. Like tubulin, FtsZ is a GTPase (5, 21, 31, 37)
which forms dynamic polymer filaments upon binding GTP (9, 16-18,
22-24, 39). Furthermore, hydrolysis of the nucleotide substrate
is required for depolymerization and thus contributes to the dynamic
nature of the filaments (22, 23). Unlike tubulin, however,
FtsZ filaments are homopolymers of a single peptide species, and FtsZ
readily binds nucleotide (5, 21, 31) as well as polymerizes
(17, 22) in the absence of divalent metal.
We initially identified the ZipA protein of Escherichia coli
based on its ability to directly bind FtsZ in vitro and showed it to be
an essential cytoplasmic membrane protein which associates with the
Z-ring in vivo (10). Depletion of ZipA leads to the formation of nonseptate filaments. FtsZ rings can still assemble in
these filaments, although the number of rings per cell mass is
significantly smaller than expected (11, 13). These
observations suggest that ZipA is required for constriction of the
septal ring and that the protein may also play a role in stabilizing
the ring structure. Support for a stabilizing role of ZipA has also
come from the finding that moderate overexpression of the protein
suppresses the instability of the Z-ring in strains with the
temperature-sensitive ftsZ84 allele (30).
To better understand the interaction between FtsZ and ZipA, we have
tested the ability of deletion derivatives of these proteins to
interact both in vitro and in vivo. We show that a small domain at the
extreme C terminus of FtsZ and a significantly larger C-terminal domain
of ZipA are both required and sufficient for the specific interaction
between the two proteins. In agreement with a recent report
(30), we also found that addition of purified ZipA protein to FtsZ polymers causes the arrangement of polymers into extensive networks of thick bundles in which individual polymers are present in a
staggered side-by-side fashion. Using deletion derivatives of ZipA, we
show that the interaction between the minimal FtsZ binding domain of
ZipA and FtsZ polymers is also sufficient to induce bundling of the polymers.
The existence of some homology between a highly charged domain in ZipA
and a domain in MAP-Tau proteins involved in binding microtubules has
led to the assertion that ZipA may be considered a MAP-Tau homolog
(30). Our results, however, show that this domain of ZipA is
dispensable for both binding to FtsZ and mediating the bundling of FtsZ polymers.
We also tested the ability of various deletion derivatives of ZipA to
substitute for the native protein in supporting cell division in vivo.
Interestingly, ZipA derivatives which lacked the small N-terminal
membrane anchor or in which the membrane anchor was replaced with that
of another type Ib protein of E. coli (DjlA), were incapable
of substituting for the native protein. Thus, whereas the C-terminal
portion of ZipA is sufficient for binding and bundling of FtsZ
polymers, it is clearly not sufficient to support cell division. In
particular, our results suggest that the membrane anchor domain of ZipA
is not merely required to anchor the protein to the membrane but may
have more specific properties which are essential to proper functioning
of ZipA in the division process.
 |
MATERIALS AND METHODS |
Strains.
Strains PB103 (dadR trpE trpA tna),
PB143/pDB346 [PB103 ftsZ0
recA::Tn10/cI857(Ts)
P
R::ftsZ+], CH5/pCH32
[PB103 zipA::aph
recA::Tn10/repA(Ts) ftsZ+
zipA+], and CH5/pDB361
(zipA::aph recA::Tn10/cI857
P
R::zipA+) have been
described previously (11). Strains BL21(
DE3)/plysS [ompT rB
mB
(PlacUV5::T7gene1)/T7lysS+)]
and HMS174(
DE3) [r m+ recA
Rifr
(PlacUV5::T7gene1)] were purchased from
Novagen. Unless stated otherwise, cells were grown at 37°C in
Luria-Bertani (LB) medium supplemented, where appropriate, with
antibiotics at 50 µg/ml (ampicillin, kanamycin, and spectinomycin),
25 µg/ml (chloramphenicol), and 12.5 µg/ml (tetracycline).
Plasmid construction.
Plasmids pMLB1113 (6),
pDB319, pDB324, pDB326, and pDR10 (10), pDR112
(28), pDR107a, pDR107b, and pDR107c (29),
pAR(
RI)59/60 (1), pGFPS65T (12), and
pPSG961-31 (3) have been described previously. Plasmids
pET16b, pET21a, pET21b, pET21c, and plysS were purchased from Novagen,
and pUC4-KIXX was purchased from Pharmacia.
Plasmids for this study were created by a combination of PCR and
standard subcloning techniques. The PCRs were performed using Vent DNA
polymerase as recommended by the supplier (New England Biolabs) and,
unless stated otherwise, using genomic DNA of strain PB103 as template.
To place transcription under control of the lac or T7
promoter, fragments were inserted into the vector pMLB1113 (or
derivatives) or into one of the pET vectors (or derivatives), respectively. PCR-derived portions of inserts were sequenced using an
ABI PRISM automated sequencer to ensure the absence of undesired mutations.
(i) FtsZ plasmids.
To construct plasmid pDB312, we performed
PCR using primers
5'-GGAGGATCCCATATGTTTGAACCAATGGAAC-3' and
5'-TTCCGGTCGACTCTTAATCAGCTTGCTTACG-3' introducing BamHI, NdeI, and
SalI sites (underlined) flanking the ftsZ open
reading frame (ORF). Digestion with NdeI and SalI resulted in an 1,156-bp fragment, which was ligated to similarly treated pET21a, yielding pDB312.
For pDR118, the above PCR product was treated with BamHI and
SalI, yielding an 1,163-bp fragment, which was ligated to
BamHI- and SalI-digested pDR107a. The resulting
plasmid encodes a 68.6-kDa Gfp-T-FtsZ fusion protein, in which the
GFPmut2 peptide is fused to the N terminus of the complete FtsZ peptide
with the linker peptide ASMTGGQQMGRGSH, which includes the
Novagen T7.tag peptide (T, underlined).
For pCH94, we used primers 5'-GGAGGATCCCATATGTTTGAACCAATGGAAC-3'
and 5'-GGTACTCGAGATAATCCGGCTCTTTCGC-3',
designed to amplify the first 1,113 bp of ftsZ. The
PCR product was treated with EcoRI, which cuts within
ftsZ, and XhoI (underlined), generating a
1,002-bp fragment which was ligated to EcoRI- and
XhoI-digested pDB312. Plasmid pCH94 encodes a 40-kDa FtsZ-H
fusion protein, in which the His tag peptide E(H)6 is fused
to the C terminus of FtsZ at amino acid 372.
Plasmid pCH95 was constructed in a similar fashion using primers
5'-GGAGGATCCCATATGTTTGAACCAATGGAAC-3' and
5'-TCCACTCGAGACCTGTCGCAACAACGG-3' to amplify the
first 942 bp of ftsZ. The plasmid encodes a 33.6-kDa FtsZ-H
fusion protein, in which the His tag peptide LE(H)6 is fused to the C terminus of FtsZ at amino acid 314.
To construct plasmid pCH105, we used primers
5'-GTCTGGATCCAACGCGACTGTGGTTATCGG-3' and
5'-TTCCGGTCGACTCTTAATCAGCTTGCTTACG-3', designed
to amplify a fragment consisting of the last 285 bp of the
ftsZ ORF flanked by BamHI and SalI
sites (underlined). Digestion with these enzymes yielded a 296-bp
fragment, which was ligated to BamHI- and
SalI-digested pDR107a, yielding pCH105. This plasmid encodes
a 38.6-kDa Gfp-T-FtsZ fusion protein, in which GFPmut2 is fused to the
N terminus of FtsZ at amino acid 289 by the linker peptide
ASMTGGQQMGRGS. Plasmid pCH109 was then obtained by ligating a 150-bp
Sau3AI-HindIII fragment from pCH105 to
BamHI- and HindIII-digested pDR107b. The
resulting plasmid encodes a 33.3-kDa Gfp-T-FtsZ fusion protein, in
which GFPmut2 is fused to the N terminus of FtsZ at amino acid 337 with
the linker peptide ASMTGGQQMGR.
For pCH122, the 1,363-bp EcoRV-PstI fragment of
pCH109 was ligated to pDR107c which had been treated sequentially with
BamHI, Klenow enzyme plus deoxynucleoside triphosphate
(dNTP), and PstI. Plasmid pCH122 codes for a 29.2-kDa
Gfp-T-FtsZ fusion protein, in which GFPmut2 is fused to the N terminus
of FtsZ at amino acid 374 by the linker peptide ASMTGGQQMGRI.
To construct pCH127, pCH109 DNA was used as template in a PCR with
primers 5'-ACACTGGATCCCAAACTGCGAAAGAGCCGG-3' and
5'-CTGAAGCTTACCAATGCTTAATCAGTGAGGC-3', which were designed
to anneal, respectively, upstream of the last 60 bp of the
ftsZ ORF and downstream of the bla gene in
pCH109. Digestion with BamHI and PstI yielded a
1,398-bp fragment which was ligated to BamHI- and
PstI-digested pDR107a, resulting in plasmid pCH127. The
plasmid codes for a 30.4-kDa Gfp-T-FtsZ fusion protein, in which the
GFPmut2 peptide is fused to the N terminus of FtsZ at amino acid 364 by
the linker ASMTGGQQMGRGS.
For pCH130, we used pDB312 DNA as template in a PCR with primers
5'-GGAGGATCCCATATGTTTGAACCAATGGAAC-3' and
5'-CGTCTACTCGAGATCAGCTTGCTTACGCAGG-3', introducing NdeI and XhoI sites
(underlined) upstream and downstream, respectively, of the
ftsZ ORF. The 1,155-bp fragment that resulted from digestion
with NdeI and XhoI was ligated to similarly
treated pET21b. Plasmid pCH130 encodes a 41.4-kDa FtsZ-H fusion
protein, in which the peptide tag LE(H)6 is fused to the C
terminus of the complete FtsZ protein.
(ii) ZipA plasmids.
For pDB322, zipA was
amplified by PCR with primers
5'-ACAGAGATCCATATGATGCAGGATTTGCGTCTG-3' and
5'-TTAACCAAGCTTAAGTGTATCAGGCGTTGG-3', designed to introduce
a NdeI site (underlined) at the translation start codon of
zipA. The PCR product was treated with NdeI
and HindIII, and the 994-bp fragment was ligated to
NdeI- and HindIII-digested pET21a,
resulting in pDB317. The 676-bp AgeI-HindIII
fragment of pDB317 was then replaced with the 1,015-bp
AgeI-HindIII fragment of pDB315, yielding
pDB318. To obtain pDB319, pDB318 was treated successively with
AflII plus HindIII, Klenow enzyme, and
ligase, thereby removing all lig sequences and retaining a
HindIII site. Plasmid pDB319 encodes the complete ZipA
protein under the control of the T7 promoter. To place zipA
expression under the control of the lac promoter, the
1,089-bp BglII-HindIII fragment of pDB319 was
ligated to BamHI- and HindIII-digested
pMLB1113, yielding pDB322.
For pCH35, the 1,733-bp chromosomal
BamHI-HindIII fragment containing the entire
zipA ORF, as well as a portion of the upstream cysZ and downstream lig ORFs, was cloned into
M13mp19 (10) and a nested set of deletions was obtained as
described previously (6). The 1,136-bp
EcoRI-HindIII fragment of one of these
deletions was ligated to similarly treated pET21c, yielding pCH35.
Plasmid pCH35 encodes a 30.5-kDa protein in which the peptide tag
MASMTGGQQMGRIRIPPPPP is fused to the N terminus of ZipA at amino
acid 70.
To construct pCH38, we performed a PCR with primers
5'-GGATCTAGACATATGATGCAGGATTTG-3' and
5'-AAGTCTCGAGGGCGTTGGCGTCTTTGAC-3' so as to
introduce NdeI and XhoI sites (underlined)
upstream and downstream, respectively, of the zipA ORF. The
986-bp fragment that resulted from an NdeI-XhoI
digestion was ligated to similarly treated pET21b. Plasmid pCH38
encodes a 37.5-kDa ZipA-H fusion protein in which the peptide tag
LE(H)6 is fused to the C terminus of the complete ZipA protein.
Plasmid pCH49 was obtained in multiple steps. The 1,265-bp
BglII-HindIII fragment of pCH35 was inserted
into BamHI- and HindIII-digested pMLB1113,
yielding pCH39. Next, pCH38 was treated sequentially with
Styl, Klenow enzyme plus dNTP, and XbaI, and the
1,112-bp fragment was ligated to pDB326 that had been treated with
AccI, Klenow enzyme plus dNTP, and XbaI, yielding
pCH41. Finally, the 1,218-bp XbaI-HindIII
fragment of pCH39 was replaced with the 1,148-bp
XbaI-HindIII fragment of pCH41. Plasmid pCH49
encodes the same fusion as pCH38, but transcription is under control of the lac promotor.
For pCH50, zipA was amplified by a PCR with primers
5'-ACAGAGATCCATATGATGCAGGATTTGCGTCTG-3' and
5'-AAGTCTCGAGGGCGTTGGCGTCTTTGAC-3', designed to
introduce a NdeI site (underlined) at the translation start
codon of zipA and to replace the translation stop codon with
an XhoI site (underlined). The product was treated with
NdeI and XhoI, and the 984-bp fragment was
ligated to NdeI- and XhoI-digested pET21b,
resulting in pCH38. Plasmid pGFPS65T contains gfpS65T on a
729-bp BamHI fragment in the vector pRSETB
(12). This fragment was ligated to BamHI-digested
pET16b, yielding plasmid pDB338, which contains an XhoI site
immediately upstream of the gfp coding sequence. The small
ApaI-XhoI fragment of pDB338 was next replaced by
that of pCH38, resulting in pDB341. This plasmid encodes a 64.2-kDa
ZipA-GfpS65T fusion protein which includes the complete ZipA and Gfp
proteins, fused by the linker peptide LEDPPAEF. To place expression of
this fusion under control of the lac promoter, the 2,126-bp
BglII-HindIII fragment of pDB341 was next
ligated to BamHI- and HindIII-digested
pMLB1113, yielding pCH50.
Plasmid pCH77 was also constructed in several steps. First, plasmid
pDB324 was digested with BamHI and HindIII,
generating a 1,214-bp fragment, which was ligated to similarly treated
pET21c. The resulting plasmid, pCH14, was digested with
BglII and HindIII, yielding a 1,354-bp
fragment that was ligated to BamHI- and
HindIII-digested pMLB1113. This new plasmid, pCH56, was
treated with AflII and HindIII, filled in
with Klenow, and then religated, removing the 328-bp
AflII-HindIII fragment at the end of the
zipA ORF, regenerating a HindIII site, and
yielding pCH57. Lastly, the 687-bp
AgeI-HindIII fragment of pCH57 was replaced
with the 1,710-bp AgeI-HindIII fragment of
pCH50, resulting in pCH77. This plasmid encodes a 61.2-kDa T-ZipA-Gfp
fusion protein, in which the peptide MASMTGGQQMGRI is fused to the N
terminus at amino acid 39 and in which the complete GfpS65T peptide is
fused to the C-terminal residue (at position 328) of ZipA with the
linker sequence LEDPPAEF.
To construct pCH78, pCH79, and pCH80, we used primers
5'-GCTTTACATATGCATGGTTTCTGGACCAGC-3' and
5'-TTAACCAAGCTTAAGTGTATCAGGCGTTGG-3', introducing NdeI and HindIII sites
(underlined), respectively, upstream of bp 67 and downstream of the
translational stop signal in the zipA ORF. Treatment with
NdeI and HindIII resulted in a 933-bp
fragment, which was ligated to similarly treated pET21a. The resulting
plasmid, pCH78, encodes a 34.2-kD ZipA peptide, beginning at amino acid
23 and continuing to its natural stop. Plasmid pCH79 was then
constructed by ligating the 1,039-bp
BglII-HindIII fragment of pCH78 to
BamHI- and HindIII-digested pMLB1113.
Finally, for pCH80, the 1,021-bp ApaI-AgeI
fragment of pCH79 was substituted for the 1,084-bp
ApaI-AgeI fragment of pCH50. Plasmid pCH80
encodes a 62.0-kDa ZipA-Gfp fusion in which GfpS65T is fused to the
C-terminal residue of ZipA(23-328) with the linker sequence LEDPPAEF.
Plasmid pCH93 was obtained with primers
5'-CGGTGGATCCCTTCTTAACAGCATTCAAC-3' and
5'-TTAACCAAGCTTAAGTGTATCAGGCGTTGG-3',
introducing BamHI and HindIII sites
(underlined) upstream and downstream, respectively, of the last 348 bp
of the zipA ORF. Digestion with BamHI and
HindIII yielded a 360-bp fragment, which was ligated to
BamHI- and HindIII-digested pDR107a. The
resulting plasmid, pCH92, encodes a 41.2-kDa Gfp-T-ZipA fusion protein,
in which the complete GFPmut2 peptide is fused to the N terminus of the ZipA peptide at amino acid 212 by the linker peptide MTGGQQMGRGS. To
place the expression of this fusion under the control of
Plac, the 1,150-bp BglII-HindIII
fragment of pCH92 was ligated to BamHI- and
HindIII-digested pMLB1113, giving rise to pCH93.
For pCH103, we used primers
5'-ACAGAGATCCATATGATGCAGGATTTGCGTCTG-3' and
5'-ATCGCTCGAGGTCAAGCACGACACCGC-3', designed to
amplify the first 906 bp of the zipA ORF. The resulting
product was treated with AgeI, which cuts within the
zipA gene, and XhoI (underlined), generating a
598-bp fragment, which was then ligated to similarly treated pCH38.
Plasmid pCH103 encodes a 34.3-kDa ZipA-H fusion protein, in which the
peptide tag LE(H)6 is fused to the C terminus of the ZipA
peptide at amino acid 302.
Plasmid pCH106 was constructed in several steps. First, plasmid pCH14
was digested with ApaI and NdeI and the small
fragment was replaced with the 1,093-bp ApaI-NdeI
fragment of pET16b. The resulting plasmid, pCH15, encodes a fusion
protein in which the first 38 amino acids of ZipA have been replaced
with a His-T7.tag (H-T) peptide. Then, the 1,710-bp
AgeI-HindIII fragment from pCH50 was ligated
to the large AgeI-HindIII fragment of pCH15,
yielding pCH106. The plasmid encodes a 63.7-kDa H-T-ZipA-Gfp fusion
protein, in which GfpS65T is fused to the C-terminal amino acid of ZipA with the linker sequence LEDPPAEF and in which the H-T peptide MG(H)10SSGHIEGRHMASMTGGQQMGRI is fused to the N
terminus at amino acid 39.
For pCH121, PCR primers
5'-GCTTTACATATGCATGGTTTCTGGACCAGC-3' and
5'-TTGGAAGCTTACAGCTCGTCACCGTAAGAC-3' were used
to introduce NdeI and HindIII sites
(underlined) upstream and downstream, respectively, of bp 67 and 837 in
the zipA ORF. The 786-bp fragment that resulted from an
NdeI-HindIII digestion was ligated to
similarly treated pET21a, generating pCH121. The plasmid encodes a
28.5-kDa peptide, consisting of residues 23 to 279 of ZipA.
To construct plasmids pCH131 and pCH132, we performed PCR with primers
5'-ACCAGGATCCGATAAACCGAAGCGCAAAGAAGCGG-3' and
5'-AAGTCTCGAGGGCGTTGGCGTCTTTGAC-3', introducing
BamHI and XhoI sites (underlined) upstream and
downstream, respectively, of the last 426 bp of the zipA
ORF. Digestion with BamHI and XhoI yielded a
431-bp fragment, which was ligated to either BamHI- and
XhoI-digested pET21a, resulting in plasmid pCH131, or
similarly treated pDR107a, to yield pCH132. Plasmid pCH131 encodes a
18.4-kDa T-ZipA-H fusion protein, in which the T7 tag MASMTGGQQMGRGS is fused to the N terminus of ZipA at amino
acid 186, while pCH132 encodes a 45.1-kDa Gfp-T-ZipA-H fusion protein in which GFPmut2 is fused to the N terminus of ZipA at amino acid 186 by the linker ASMTGGQQMGRGS. In addition, both fusions carry the peptide tag LE(H)6 fused to their C-terminal ends.
For pCH136, we used primers
5'-CGGTGGATCCCTTCTTAACAGCATTCAAC-3' and
5'-AAGTCTCGAGGGCGTTGGCGTCTTTGAC-3', introducing
BamHI and XhoI sites (underlined) upstream and
downstream, respectively, of the last 348 bp of the zipA
ORF. Digestion with BamHI and XhoI yielded a
353-bp fragment, which was ligated to BamHI- and
XhoI-digested pDR107a. The resulting plasmid, pCH136,
encodes a 42.3-kDa Gfp-T-ZipA-H fusion protein, in which GFPmut2 is
fused to the N terminus of the ZipA peptide at amino acid 212 by the
linker peptide ASMTGGQQMGRGS and in which the peptide tag
LE(H)6 is fused at the C-terminal end.
Plasmid pCH138 was obtained by replacing the 962-bp
XbaI-KpnI fragment of pCH93 with the 1,040-bp
XbaI-KpnI fragment of pCH132. Plasmid pCH138
encodes a 44.0-kDa Gfp-T-ZipA fusion protein which is similar to that
encoded by pCH132 except that it ends at the natural stop codon of
zipA and thus lacks the C-terminal LE(H)6 tag.
Plasmid pCH148 was constructed by first replacing the 1,026-bp
XbaI-XhoI fragment of pCH50 with the 948-bp
XbaI-XhoI fragment of pCH103, generating plasmid
pCH139. Then the 2,052-bp ApaI-NcoI fragment of
pDR112 was replaced with the 948-bp ApaI-NcoI
fragment of pCH139. Plasmid pCH148 encodes a 61.0-kDa ZipA-Gfp fusion
protein in which the complete GFPmut2 peptide is fused to the C
terminus of the ZipA peptide at amino acid 302 by the linker sequence LEDPPAEF.
For pCH172, plasmid pCH166 was first constructed by ligating the 936-bp
NdeI-HindIII fragment, carrying the coding
sequence for ZipA(23-328), of pCH78 to similarly treated pPSG961-31.
The djlA-zipA fusion was then put under control of
Plac by ligating the 1,068-bp
EcoRI-HindIII fragment from pCH166 to
EcoRI- and HindIII-digested pMLB1113,
yielding pCH168. Loss of a base during the generation of pPSG961-31
inadvertently resulted in a translational fusion between the 5' end of
lacZ, present in the pMLB1113 vector, and the
djlA-zipA ORF. To place the fusion out of frame with
lacZ sequences, pCH168 was digested with EcoRI,
treated with Klenow, and religated. The resulting plasmid, pCH172,
encodes a 37.4-kDa DjlA-ZipA fusion protein in which the transmembrane
domain of DjlA (residues 1 to 32) is fused to the N terminus of ZipA at amino acid 23.
Plasmid pCH174 was constructed by replacing the 1,040-bp
ApaI-AgeI fragment of pCH50 with the 1,043-bp
ApaI-AgeI fragment of pCH172. Plasmid pCH174
encodes a 65.2-kDa DjlA-ZipA-Gfp fusion protein in which GfpS65T is
fused to the C-terminal amino acid of DjlA-ZipA with the linker
sequence LEDPPAEF.
For pCH182, the 1,026-bp XbaI-XhoI fragment of
pCH49 was replaced with the 948-bp XbaI-XhoI
fragment of pCH103, thereby placing the expression of the
ZipA(1-302)-H fusion under the control of Plac.
For pAB10, we made use of plasmid pAR(
RI)59/60 (1), which
contains a 54-bp NdeI fragment encoding the peptide
MDYKDDDDKARRASVEF. This peptide, denoted as FK, is a fusion
of the Flag peptide (IBI) with a heart muscle kinase substrate peptide
(underlined). To ease the manipulation of the NdeI cassette,
a ~1,800-bp EcoRI fragment, isolated from pUC4-KIXX and
carrying the Tn5 aph(neo) gene, was inserted in
the EcoRI site of pAR(
RI)59/60, which is flanked by the
NdeI sites. The ~1,850-bp NdeI fragment of the resulting plasmid, pTD1, was treated with Klenow and ligated to XhoI-digested and Klenow-treated pCH38 in the desired
orientation to yield pAB9.5. To remove the ~1,800-bp stuffer
fragment, the latter was treated with EcoRI and
recircularized, generating pAB10. This plasmid encodes a 39.9-kDa
ZipA-FKH fusion protein in which the peptide
LDMDYKDDDDKARRASVEFHIE(H)6 is fused to the C terminus of
the complete ZipA protein.
Protein purification.
BL21(
DE3)/plysS cells carrying the
appropriate pET-derived plasmid were grown overnight in LB medium with
50 µg of ampicillin per ml, 25 µg of chloramphenicol per ml, and
0.1% glucose. Cultures were diluted 1:200 in 500 ml of LB with 50 µg
of ampicillin per ml and 0.04% glucose and grown at 30 or 37°C to an
optical density at 600 nm (OD600) of 0.4 to 0.5. Isopropyl-
-D-thiogalactoside (IPTG) was added to 0.84 mM, and growth continued for another 2 h. Cells were harvested by
centrifugation, washed once in 0.9% saline, and resuspended in cell
breakage buffer (specified below) to a final volume of 5 ml. Cell
suspensions were subjected to three rapid freeze-thaw cycles using a
dry ice-acetone bath and a 37°C water bath. Cell lysis was monitored
by phase-contract microscopy. The cell lysates were briefly sonicated
to reduce viscosity and fractionated into pellet (P200) and supernatant (S200) fractions by centrifugation at 200,000 × g for
3 h at 5°C. After purification, the proteins were rapidly frozen
in a dry ice-acetone bath and stored at
80°C.
ZipA(23-328), ZipA(23-279), and T-ZipA(70-328) were expressed from
plasmids pCH78, pCH121, and pCH35, respectively. Cells were broken in
20 mM Tris-Cl (pH 8.0)-25 mM NaCl-5 mM EDTA, and the bulk of these
proteins fractionated with the supernatant as judged by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analyses.
Proteins in the S200 fractions were precipitated by addition of
ammonium sulfate to 30% saturation and centrifugation at
8,000 × g for 20 min at 4°C. The pellets were
resuspended in a minimal volume (0.5 to 1.0 ml) of 20 mM Tris-Cl (pH
8.0)-25 mM NaCl-5 mM EDTA and dialyzed extensively against the same
solution. The dialysates were further fractionated by fast protein
liquid chromatography on an Uno Q column (Bio-Rad) with a linear 25 to 500 mM NaCl gradient in the same buffer. ZipA(23-328) and
ZipA(23-279) both eluted in a sharp peak at 210 mM NaCl, while
ZipA(70-328) eluted at 100 mM NaCl. Peak fractions were dialyzed
extensively against 20 mM Tris-Cl (pH 8.0)-25 mM NaCl-2 mM EDTA
before storage.
H-T-ZipA(39-328)-Gfp, T-ZipA(186-328)-H, Gfp-T-ZipA(186-328)-H, and
Gfp-T-ZipA(212-328)-H were expressed from plasmids pCH106, pCH131,
pCH132, and pCH136, respectively. Cells were broken in 20 mM Tris-Cl
(pH 7.9)-70 mM NaCl-50 mM imidazole [NiB(70/50)]. Almost all of the
desired proteins were present in the corresponding S200 fractions.
These were passed through a 1-ml fast-flow chelating Sepharose column
(Pharmacia) that had been charged with NiCl2 and
equilibrated with NiB(70/50) buffer. The columns were washed with
NiB(500/50) (as above but containing 500 mM NaCl and 50 mM imidazole),
and bound protein was eluted in NiB(500/500) (500 mM NaCl and 500 mM
imidazole). EDTA was added to 5 mM, and peak fractions were dialyzed
extensively against 20 mM Tris-Cl (pH 8.0)-25 mM NaCl-2 mM EDTA.
ZipA(1-328)-H, ZipA(1-328)-FKH, and ZipA(1-302)-H were expressed
from plasmids pCH38, pAB10, and pCH103, respectively, and cells were
broken in NiB(70/50) as above. Very little of these proteins was
recovered in the S200 fractions. Rather, ZipA(1-328)-H and
ZipA(1-328)-FKH were almost equally distributed in the pellet fraction
and in an opaque interphase zone which was easily visible just above
the solid pellet material. The interphase material was collected, and
Triton X-100 was added to 0.1%. For ZipA(1-302)-H, no interphase zone
was visible and the protein was present exclusively in the pellet
fraction. This fraction was resuspended in NiB(70/50) containing 0.5%
Triton X-100. After a second centrifugation step, the bulk of all three
proteins remained in the supernatant fraction, indicating that they
were effectively solubilized by the detergent, as is also the case with
native ZipA (10). The proteins were further purified on
chelating Sepharose as described above, except that 0.02%
[ZipA(1-328)-H and ZipA(1-328)-FKH], or 0.05% [ZipA(1-302)-H] Triton X-100 was included in all the buffers. ZipA(1-328)-FKH and
ZipA(1-302)-H were used after this step. The ZipA(1-328)-H was
further purified by fast protein liquid chromatography on a Mono-Q
column (Pharmacia) with a linear 25 to 500 mM NaCl gradient in 20 mM
Tris.Cl (pH 8.0)-2 mM EDTA-0.02% Triton X-100. The protein eluted in
a sharp peak at 380 mM NaCl. Peak fractions were dialyzed against 20 mM
Tris-Cl (pH 8.0)-25 mM NaCl-2 mM EDTA-0.02% Triton X-100, and the
protein was concentrated with a Centricon-10 device (Amicon) before storage.
Native FtsZ(1-383) was expressed from plasmid pDB312, and cells were
lysed in 50 mM Tris.Cl (pH 7.9)-50 mM KCl-1 mM EDTA-10% glycerol.
The protein was subsequently purified as described previously (23).
FtsZ(1-383)-H, FtsZ(1-372)-H, and FtsZ(1-314)-H were expressed from
plasmids pCH130, pCH94, and pCH95, respectively. The proteins were
purified from S200 fractions on chelating Sepharose essentially as
described above for the soluble His-tagged ZipA derivatives, except
that KCl was substituted for NaCl and glycerol was present at 10% in
all buffers. Peak fractions were dialyzed into 50 mM HEPES hydroxide
(pH 7.2)-0.1 mM EDTA-10% glycerol for storage. HFKT-FtsZ(1-383) was
obtained as described previously (10).
FtsZ polymerization.
FtsZ was added to polymerization buffer
(50 mM morpholineethanesulfonic acid [MES], 50 mM KCl, 10 mM
MgCl2, 1 mM GTP [pH 5.8]) and incubated at 30°C for 5 min. A ZipA derivative (or ZipA storage buffer for ZipA
controls) was added, and incubation was continued for another 10 min.
The final reaction volume was 50 µl, and the final concentration of
each protein was 5 µM. A 10-µl volume of the reaction mixture was
spotted on a glow-discharged, carbon-coated copper grid (300 mesh).
After 20 s, the grid was wicked dry with filter paper, stained
with 1% uranyl acetate for 45 s, and wicked dry again. For some
reactions, GDP was used instead of GTP, and/or MgCl2 was
omitted and EDTA was added to 2 mM. Polymerization of FtsZ(1-314)-H was carried out in the same way, except that the pH of the buffer was
6.0. The grids were viewed and photographed on a JEOL 100CX or JEOL
1200CX transmission electron microscope at 80 kV. Negatives were
scanned using a Dimage Scan Multi (Minolta), and images were manipulated using Adobe Photoshop.
For fluorescence-based assays, polymerization reactions were carried
out as above, except that FtsZ was used at 6.0 µM and Gfp-tagged ZipA
derivatives were used at either 6.0 or 0.6 µM. Samples were applied
to a microscope slide and viewed with a plan-NEOFLUAR (100×; numerical
aperture [NA] = 1.3) objective on a Zeiss Axioplan-2 fluorescence microscope equipped with a cooled charge-coupled device
camera (Hamamatsu), using a 495-nm dichroic mirror, a 450- to 490-nm
excitation filter, and a 500- to 550-nm barrier filter. Images were
captured using QED software and further manipulated using Adobe Photoshop.
Affinity blotting.
Purified HFKT-FtsZ and ZipA-FKH were
phosphorylated as described previously (10) to specific
activities of 1.0 × 107 and 4.3 × 106 cpm/µg, respectively. Subsequent procedures were
performed as described previously (10).
Protease accessibility.
The preparation of spheroplasts and
determination of protease accessibility were done essentially as
described previously (2). Briefly, an overnight culture of
strain PB103 was diluted 100-fold in 20.0 ml of LB broth and grown
37°C to an OD600 of 0.5. The cells were harvested by
centrifugation and resuspended in 0.15 ml of 30 mM Tris-Cl (pH 8.0)
containing 25% sucrose. The resuspended cells were mixed with an equal
volume of a solution containing 10 mM EDTA and 0.4 mg of lysozyme per
ml in water, and the mixture was incubated at room temperature (RT) for
3.0 min. As judged by phase-contrast microscopy, virtually all the cells had been converted to spheroplasts at this point. Aliquots of 50 µl were either left untreated or treated with protease and/or detergent by addition of proteinase K to 150 µg/ml (1.6 µl of a
5-mg/ml stock) and/or Triton-X100 to 0.1% (1.0 µl of a 5% stock), respectively. After 5 min at RT, 5.0 µl of a 50 mM solution of phenylmethylsulfonyl fluoride in ethanol was added to each sample, and
after an additional 5 min at RT, each sample was mixed with 55 µl of
2× SDS-PAGE sample buffer. Samples were incubated at 100°C for 10 min, aliquots (20 µl per lane) were used to prepare three identical
SDS-PAGE gels, and proteins were blotted to nitrocellulose filters. One
filter was incubated with monoclonal antibody 4H4 to detect TonB
(27). FtsZ was detected with a polyclonal antiserum (11), and ZipA was detected by incubation of the remaining
filter with radiolabeled HFKT-FtsZ (10).
Quantitative immunoblotting.
To determine the cellular
levels of plasmid-encoded ZipA and derivatives (see Table 2), cells
were harvested by centrifugation, resuspended in SDS-PAGE
electrophoresis sample-lysis buffer (7) to the equivalent of
13.3 OD600 units per ml, and incubated at 100°C for 5 min. The resulting lysates were further diluted in sample buffer as
needed. Samples were separated by SDS-PAGE and transferred to
nitrocellulose filters. The filters were incubated with
affinity-purified ZipA antibodies and subsequently with enhanced chemiluminescence reagents using an Amersham-Pharmacia ECL kit as
recommended by the manufacturer. Chemiluminescent signals were visualized and quantified using a Fluor-S MAX Multiimager system and
Quantity One software (Bio-Rad). Each filter contained a reference lane
loaded with 10.0 × 10
3 OD600 equivalent
(corresponding to 8.0 µg of total protein) of a PB103/pMLB1113
H
extract to establish the level of chromosomally encoded native ZipA in
wild-type cells. Adjacent lanes were loaded with 2.0 × 10
3 and 1.0 × 10
3 OD600
equivalents (corresponding to 1.6 and 0.8 µg of total protein, respectively) of each relevant extract to determine the level of
plasmid-encoded antigen. Signals showed optimal linearity with the
amount of antigen under these conditions, as established in pilot
experiments. Since the ZipA derivatives migrated close to the
position of native ZipA in the gels, the combined signal was measured. Based on the signal in the reference lane, and accounting for
dilution factors, the contribution of chromosomally encoded native ZipA
was calculated and subtracted from the total signal to obtain the
contribution of plasmid encoded ZipA.
 |
RESULTS |
A small C-terminal domain of FtsZ is required and sufficient for
interaction with ZipA.
We previously detected the ZipA protein by
an affinity-blotting procedure in which a radiolabeled derivative of
the FtsZ protein was incubated with Western blots containing ZipA on
nitrocellulose filters (10). To delineate the portion of
FtsZ involved in the interaction with ZipA, we used a converse approach
in which radiolabeled ZipA was incubated with immobilized FtsZ. As
probe we used a derivative of ZipA (ZipA-FKH) consisting of the
complete ZipA peptide carrying a C-terminal tag peptide (FKH) which
includes a substrate site for heart muscle kinase (K) and a stretch of
six histidine residues (H). Purified ZipA-FKH was radiolabeled with
32P and incubated with filters containing native FtsZ as
well as a variety of derivatives in which portions of FtsZ were fused to Gfp and/or polyhistidine tags (Fig.
1).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
FtsZ plasmids used to define the ZipA-binding domain.
(a) The physical map of ftsZ and portions of flanking genes
in E. coli are shown at the top of the panel. The positions
of BclI (Bc), EcoRI (E), EcoRV (Rv),
and HindIII (H) restriction sites are indicated. The
positions in the E. coli FtsZ polypeptide of two domains (N
and C) and a connecting core helix (residues ca. 177 to 201) were
inferred from the crystal structure of FtsZ from Methanococcus
jannaschii (14, 15). Inserts of plasmids are presented
below the map, and the FtsZ residues they encode are given at the right
of each insert. All plasmids were derivatives of pET21, such that
transcription of inserts was under control of the T7lac
promoter (Novagen). Plasmid pDB312 encodes native FtsZ. All others
encode either full-length or portions of FtsZ fused to various tags, as
indicated. H6, stretch of six histidine residues; HFKT,
combination tag peptide which includes a stretch of 10 histidine
residues and a substrate site for heart muscle kinase (10);
T, T7.tag peptide. (b) The ability of these FtsZ derivatives to bind
radiolabeled ZipA-FKH was determined by affinity blotting. +, protein
binds ZipA; , protein does not bind ZipA.
|
|
As shown in Fig. 2, the ZipA probe
readily recognized purified untagged FtsZ (383 amino acids [aa]) on
Western blots (lanes 1). ZipA-FKH also bound well to a version
containing a His6 tag at the C terminus of the
complete FtsZ protein [FtsZ(1-383)-H] (lanes 2), indicating that
addition of the tag did not substantially interfere with the
interaction between the two proteins. In contrast, deletion derivatives
containing residues 1 to 314 or 1 to 372 failed to bind the ZipA probe
(lanes 4 and 3, respectively), indicating that removal of as little as
10 residues from the C terminus of FtsZ abolished its interaction with
ZipA-FKH.

View larger version (117K):
[in this window]
[in a new window]
|
FIG. 2.
Binding of radiolabeled ZipA to a C-terminal domain of
FtsZ. Purified proteins (lanes 1 to 4) and whole-cell extracts (lanes 5 to 8) were separated on two identical SDS-PAGE gels. One gel was
stained with Coomassie brilliant blue to visualize protein bands (top),
and proteins in the other gel were blotted to a nitrocellulose filter
which was subsequently incubated with radiolabeled ZipA-FKH (bottom).
Lanes 1 to 4 contain 50 pmol of native FtsZ(1-383) (lane 1),
FtsZ(1-383)-H (lane 2), FtsZ(1-372)-H (lane 3), or FtsZ(1-314)-H
(lane 4). Lanes 5 to 8 contain 10 µl of extract of cells
overexpressing Gfp-T-FtsZ(1-383) (lane 5), Gfp-T-FtsZ(289-383) (lane
6), Gfp-T-FtsZ(364-383) (lane 7), or Gfp-T-FtsZ(374-383) (lane 8).
Extracts were prepared from cells of strain BL21( DE3)/plysS
containing the appropriate plasmid (Fig. 1) after growth in the
presence of IPTG and by resuspension of cells in SDS-PAGE lysis buffer
to the equivalent of 20.0 OD600 units. Bands corresponding
to the overexpressed proteins are indicated by an asterisk in the upper
panel. The positions of molecular mass standards (66, 45, 36, 29, and
24 kDa [top to bottom]) are indicated on the left of the panels.
|
|
To delineate the ZipA binding domain of FtsZ further, we next tested
the binding of ZipA to a set of derivatives in which Gfp was fused to
various portions of the C terminus of FtsZ. The fusions were all
overexpressed in strain BL21(
DE3)/plysS, and whole-cell lysates were
used for affinity blotting with radiolabeled ZipA-FKH. As shown in Fig.
2, a fusion containing the last 20 residues of FtsZ (lanes 7) bound the
probe as well as did fusions containing larger portions of the protein
(lanes 5 and 6), whereas a fusion containing only the last 10 residues
completely failed to bind (lanes 8). We conclude that the C-terminal 20 residues of FtsZ include elements that are both required and sufficient for the specific interaction of the protein with ZipA.
FtsZ interacts with the cytoplasmic C-terminal domain of ZipA in
vitro.
Membrane fractionation studies, in combination with the
deduced primary sequence of ZipA, indicated that the protein is a bitopic integral inner membrane species of type lb, with the N terminus
anchored in the membrane and the rest of the protein in the cytoplasm
(10). To further validate this assignment, spheroplasts
derived from wild-type strain PB103 were incubated with proteinase K in
the presence or absence of the detergent Triton X-100, and the fate of
ZipA was monitored by affinity blotting with radiolabeled HFKT-FtsZ. As
controls, we performed immunoblot analyses on the same samples to
determine the fates of FtsZ, a cytoplasmic protein, and of TonB, a type
II transmembrane protein of which the bulk is present in the periplasm
(27). Addition of proteinase K to detergent-permeabilized
spheroplasts led to the complete degradation of all three proteins
(Fig. 3, lanes 3), confirming that all
three are good substrates for the protease. In contrast, treatment of
intact spheroplasts with protease led to the specific degradation of
TonB whereas the bulk of both FtsZ and ZipA remained unaffected (lanes
1). These results support a largely cytoplasmic localization of ZipA
and indicate that if any part of ZipA is exposed to the periplasm (such
as the extreme N-terminal portion), it must be very small.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Protease inaccessibility of ZipA in intact spheroplasts.
Spheroplasts of PB103 cells were either left untreated (lanes 2) or
treated with protease (lanes 1 and 3) and/or detergent (lanes 3 and 4).
Samples were used to prepare three identical Western blots. TonB (top)
and FtsZ (bottom) were detected with specific antibodies; ZipA (middle)
was detected by incubation of the blot with radiolabeled HFKT-FtsZ.
|
|
The proposed membrane anchor domain of ZipA (aa 1 to 24) is followed by
a highly charged domain (aa 25 to 84), a proline- and glutamine-rich
domain (aa 85 to 187), and a C-terminal domain (aa 188 to 328)
(10). To delineate the portion of ZipA required for FtsZ
binding, we tested the ability of purified derivatives of ZipA, lacking
various portions of the native protein, to bind radiolabeled HFKT-FtsZ
in affinity blot assays (Fig. 4 and
5). During
purification of these derivatives it became evident that each species
that still contained the proposed membrane anchor domain of native ZipA
fractionated with the insoluble material of broken cells. As with
native ZipA, however, these species could be readily solubilized by
extraction of pellet fractions with nonionic detergent. In contrast,
each ZipA derivative lacking the first 22 (or more) residues behaved as
soluble species, even in the absence of detergent. These observations
are fully consistent with the proposal that the N terminus of ZipA
functions as the sole membrane anchor.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
ZipA plasmids used to define the FtsZ-binding domain.
(a) The physical map of zipA and portions of flanking genes
in E. coli are shown at the top of the panel. The positions
of AflII (Af), BamHI (B), HindIII
(H), KpnI (K), and PvuII (Pv) restriction sites
are indicated. The four domains of the ZipA polypeptide we previously
proposed are denoted N (N-terminal membrane anchor), +/ (highly
charged domain), P/Q (proline- and glutamine-rich domain), and C
(C-terminal domain). The +/ domain includes the MAP-Tau repeat-like
sequence proposed by RayChaudhuri to mediate binding to and bundling of
FtsZ polymers (30). Inserts of plasmids are presented below
the map, and the ZipA residues they encode are given at the right of
each insert. All plasmids were derivatives of pET21, such that
transcription of inserts was under the control of the T7lac
promoter (Novagen). As indicated, inserts encode either full-length or
portions of ZipA fused to various tags. H10, stretch of 10 histidine residues; FKH, combination tag which includes a stretch of
six histidine residues and a substrate site for heart muscle kinase.
See also the legend to Fig. 1. (b) The ability of these ZipA
derivatives to bind radiolabeled HFKT-FtsZ was determined by affinity
blotting. +, protein binds FtsZ; , protein does not bind FtsZ. The
ability of proteins to bundle FtsZ polymers was assessed by electron
microscopy in all cases. The results obtained with the three Gfp-tagged
derivatives were confirmed by fluorescence microscopy. +, numerous
bundles and bundle networks observed. , no bundles observed.
|
|

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 5.
Binding of radiolabeled FtsZ to a C-terminal domain of
ZipA. Purified proteins (50 pmol/lane) were separated on two identical
SDS-PAGE gels. One gel was stained with Coomassie brilliant blue to
visualize protein bands (top), and proteins in the other gel were
blotted to a nitrocellulose filter which was subsequently incubated
with radiolabeled HFKT-FtsZ (bottom). Lanes contained ZipA(1-328)-H
(lane 1), ZipA(1-302)-H (lane 2), ZipA(23-328) (lane 3),
ZipA(23-279) (lane 4), T-ZipA(70-328) (lane 5), T-ZipA(186-328)-H
(lane 6), Gfp-T-ZipA(186-328)-H (lane 7), or Gfp-T-ZipA(212-328)-H
(lane 8). The positions of molecular mass standards (66, 45, 36, 29, 24, 20, and 14 kDa [top to bottom]) are indicated on the left of the
panels.
|
|
As shown in Fig. 5, radiolabeled HFKT-FtsZ readily recognized
ZipA(23-328) on affinity blots, demonstrating that the membrane anchor
of ZipA is not required for binding FtsZ (lanes 3). Moreover, the probe
bound equally well to ZipA(70-328), a derivative which lacks both the
membrane anchor and 25 of the 29 charged residues of the highly charged
domain, showing that the charged domain is also not required for
binding to FtsZ in vitro (lanes 5). Evidence that the PQ-rich domain is
also dispensable came from the finding that the probe also bound to
Gfp-T-ZipA(186-328)-H (lanes 7). The latter is a protein fusion in
which the N-terminal three domains of ZipA were replaced with a 251-aa
peptide, which consists of Gfpmut2 (Gfp) and the T7.tag peptide (T) and
which carries a His6 tag fused to the C-terminal residue of
ZipA. Binding of HFKT-FtsZ to this fusion was specific to the ZipA
portion since the Gfp-T peptide or the H tag by themselves showed no
affinity for the probe (data not shown) and since a similar fusion,
from which additional ZipA residues were removed
[Gfp-T-ZipA(212-328)-H] was not recognized by the probe (lanes 8).
These results demonstrated that FtsZ binds the C-terminal domain
(C-domain, aa 186 to 328) of ZipA and, moreover, that residues at the N
terminus of this domain (aa 186 to 211) are required for binding.
Residues at the C-terminal end of this domain are also important for
this property, since deletion of as little as 26 residues from the C
terminus of ZipA [ZipA(1-302)-H (lanes 2)] also completely abolished
its ability to bind HFKT-FtsZ.
We conclude that the FtsZ binding domain (FZB domain) of ZipA is
confined to the C-terminal portion (aa 186 to 328) of the protein. The
finding that small deletions from either end of this domain preclude it
from binding the probe suggests that the integrity of this
complete domain is important for binding FtsZ in this assay.
In this regard, it is noteworthy that T-ZipA(186-328)-H, which
contains the complete FZB domain but lacks the Gfp tag, failed to bind
probe in the affinity-blotting assay (lanes 6). The simplest
interpretation of this result is that direct binding of the untagged
FZB domain to the nitrocellulose support precludes a subsequent
interaction with FtsZ because the FtsZ binding site is no longer
accessible, or because binding to the support prevents it from adopting
a proper configuration. We envision that the Gfp peptide in the
Gfp-T-ZipA(186-328)-H fusion allows molecules of the fusion to adhere
to the support through the Gfp portion while allowing the FZB domain to
adopt or retain its proper conformation for FtsZ binding.
The FZB domain directs ZipA to the septal ring in vivo.
We
previously showed that ZipA localizes to the septal ring organelle in a
FtsZ-dependent manner (10, 11). As shown above, the FZB
domain of ZipA is required and sufficient for binding to FtsZ in vitro.
To test whether this domain is also sufficient to direct the ZipA
protein to the FtsZ ring in vivo, we examined the cellular localization
of derivatives containing various portions of ZipA fused to Gfp (Fig. 6
and
7).
As observed previously (10, 11), virtually all fluorescence
was seen associated with the septal ring structure in the vast majority
of cells of strain PB103/pCH50
[wt/Plac::zipA(1-328)-gfp],
which express a fusion of the full-length ZipA peptide with Gfp (Fig.
7A). In contrast, in PB103/pCH148
[wt/Plac::zipA(1-302)-gfp]
cells, which express a derivative lacking the C-terminal 26 aa of ZipA,
fluorescence failed to accumulate at the septal ring. Rather, this
fusion appeared to be evenly distributed along the entire periphery of
the cell (Fig. 7B). Combined with the observations that ZipA(1-302)-H
fractionates with the insoluble fraction of cells and that the protein
fails to bind FtsZ in vitro, this distribution indicates that whereas the fusion is still anchored to the cytoplasmic membrane by the ZipA
N-terminal membrane domain, it no longer recognizes FtsZ that has
accumulated within the septal ring.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 6.
Plasmids used to sublocalize ZipA derivatives. (a) The
C-domain of ZipA is renamed FZB (FtsZ-binding domain) to indicate that
this domain coincides with the portion of ZipA found here to be
required and sufficient for binding FtsZ (see the text). Inserts were
cloned into the vector pMLB1113 such that expression of the fusion
proteins is under control of the lac promoter and
lacIq. D, transmembrane domain corresponding to
residues 1 to 32 of DjlA. See also the legend to Fig. 1. (b) Cellular
location of fusion proteins in strain PB103. R, virtually all
fluorescence associated with the septal ring; M, fluorescence evenly
distributed along the entire cell membrane; C, fluorescence evenly
distributed throughout the cytoplasm; C/R, a significant portion of
total fluorescence throughout the cytoplasm and the rest associated
with the septal ring.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 7.
Localization of Gfp-tagged ZipA derivatives in wild-type
cells. Cells were chemically fixed and observed under fluorescence (A
to F) and differential interference contrast (A' to F') optics. Images
faithfully reflected the distributions of fluorescence seen prior to
fixation. Panels show cells of strain PB103 (wild type) expressing ZipA
derivatives from plasmids pCH50
[Plac::zipA(1-328)- gfp] (A), pCH148
[Plac::zipA(1-302)-gfp] (B),
pCH80
[Plac::zipA(23-328)-gfp]
(C), pCH138 [Plac::gfp-t-zipA(186-328)]
(D), pCH93 [Plac::gfp-t-zipA(212-328)]
(E), or pCH174
[Plac::djlA(1-32)-zipA(23-328)-gfp]
(F). Cells were grown in the presence of 5 µM (A), 10 µM (B), 25 µM (C), or 100 µM (D to F) IPTG. None of the plasmids interfered
noticeably with the normal division phenotype under these conditions.
Bar, 3 µm.
|
|
Fusions containing an intact FZB domain but lacking the membrane domain
showed a different distribution. Thus, cells expressing ZipA(23-328)-Gfp (PB103/pCH80) showed a high signal throughout the
cell body in addition to a distinct accumulation at the middle of cells
(Fig. 7C). Consistent with the binding studies above, this pattern
indicates that the absence of the transmembrane domain of ZipA does not
preclude the protein from interacting with the FtsZ ring in vivo. To
ensure that the apparent accumulation at the septal ring we observed
with this fusion was in fact dependent on FtsZ, we also determined the
distribution of this fusion in cells from which FtsZ had been depleted
(Fig. 8). For this experiment, we made
use of the previously described strain PB143/pDB346
[ftsZ0/cI857
P
R::ftsZ], which allows for a
cold-induced depletion of FtsZ (11). This strain, containing
either pCH50 or pCH80, was grown in the presence of IPTG and shifted
from 42 to 30°C to repress the expression of ftsZ.
Fluorescent rings were absent in the resulting filaments of both
PB143/pDB346/pCH50 and PB143/pDB346/pCH80. The bulk of ZipA-Gfp
in PB143/pDB346/pCH50 filaments appeared evenly distributed along
the membrane (Fig. 8A). In a small fraction of filaments, some periodic
accumulations of fluorescence, which might represent ZipA-Gfp binding
to minor assemblies of the remaining FtsZ, could still be discerned. In
contrast, ZipA(23-328)-Gfp appeared dispersed throughout the cytoplasm
in the FtsZ-depleted filaments of strain PB143/pDB346/pCH80 (Fig. 8B).
In combination with the fractionation and binding studies above, these
results show that removal of the membrane anchor of ZipA yields a
soluble species capable of binding FtsZ both in vitro and in vivo.

View larger version (99K):
[in this window]
[in a new window]
|
FIG. 8.
Localization of Gfp-tagged ZipA derivatives in
FtsZ cells. Filaments of the FtsZ CID strain PB143/pDB346
(ftsZ0/cI857
P R::ftsZ) carrying pCH50
[Plac::zipA(1-328)-gfp] (A),
pCH80 [Plac::zipA(23-328)-gfp]
(B), or pCH174
[Plac::djlA(1-32)-zipA(23-328)-gfp]
(C) are shown. Cells were grown at 30°C (leading to depletion of
FtsZ) in the presence of 5 µM (A and B) or 100 µM (C) IPTG. The
resulting filaments were chemically fixed and observed under
fluorescence optics. Images faithfully reflected the distributions of
fluorescence seen prior to fixation. Bar, 3 µm.
|
|
A fusion containing just the FZB domain [Gfp-ZipA(186-328)] of ZipA
showed a distribution (Fig. 7D) indistinguishable from that of
ZipA(23-328)-Gfp (Fig. 7C). In contrast, Gfp-ZipA(212-328) did not
accumulate at septal rings but was evenly distributed throughout the
cytoplasm (Fig. 7E). In summary, the results of these localization
studies directly paralleled those of our binding studies, and we
conclude that the FZB domain of ZipA is not only required and
sufficient for binding to FtsZ in vitro but also required and
sufficient for recruitment to the FtsZ ring in vivo.
ZipA-induced bundling of FtsZ protein filaments in vitro.
Using an optimized purification protocol for FtsZ, Mukherjee and
Lutkenhaus (23) recently showed that the protein can readily form homopolymeric protein filaments in a strictly GTP-dependent fashion and in the absence of additional promoting agents such as
DEAE-dextran, cationic phospholipids, or high concentrations of
Ca2+, which had been used in earlier studies (9, 24,
35, 39). In addition, it was shown that whereas FtsZ can bind
nucleotide and form filaments in the absence of divalent metals
(5, 21, 23, 31), Mg2+ is required for hydrolysis
of GTP (5, 21, 31), which, in turn, is correlated with the
ability of filaments to depolymerize (22).
To assess the effect of ZipA on FtsZ polymers, we purified FtsZ by the
method of Mukherjee and Lutkenhaus (23), and incubated the
protein with GTP and Mg2+ for 5 min at 30°C to allow
polymers to form. We next added buffer or buffer containing various
purified ZipA derivatives, and after an additional 10 min of
incubation, samples were prepared for analysis by negative-stain
electron microscopy (EM). Similar to what was described before
(23), buffer control samples showed the presence of numerous
polymers of variable length and a diameter of approximately 5 to 7 nm
(Fig. 9A). The vast majority of
structures appeared as individual filaments, and bundles in which more
than a few polymers were closely apposed were rare. Furthermore,
consistent with the previous reports (22, 23), polymers
formed readily when Mg2+ was omitted but were completely
absent when GDP was substituted for GTP (see below) (data not shown).

View larger version (188K):
[in this window]
[in a new window]
|
FIG. 9.
ZipA-induced bundling of FtsZ polymer filaments.
Purified native FtsZ (A to E) and FtsZ(1-314)-H (F and G) was
incubated in the presence of 1.0 mM GTP and in the presence of either
10 mM Mg2+ (A, B, and D to G) or 2 mM EDTA (C). After 5 min, buffer (A and F), ZipA(23-328) (B, C, and G),
Gfp-T-ZipA(186-328)-H (D), or Gfp-T-ZipA(212-328)-H (E) was added.
After an additional 10 min, samples were applied to a microscope grid,
stained with uranyl acetate, and examined under an electron microscope.
Each protein in the reactions was present at 5 µM. The inset in panel
B represents a portion (arrow) of the bundle network in more detail,
emphasizing the side-by-side arrangement of polymers within the
bundles. Polymers or polymer bundles were completely absent in control
reactions in which GTP or FtsZ were omitted (data not shown). Bar, 76 nm (C), 100 nm (A, E to G, and inset in B), 125 nm (D), or 600 nm
(B).
|
|
Interestingly, addition of purified ZipA(23-328) induced the formation
of large protein structures in which numerous FtsZ polymers were
arranged in a side-by-side fashion, resulting in bundles which
themselves were most often arranged in extensive networks (Fig. 9B).
Whereas the bulk of individual filaments were 100 to 500 nm long,
bundles were frequently a few micrometers in length and their width
typically ranged from 70 to 500 nm. Identical structures were seen in a
similar reaction in which FtsZ was incubated with ZipA(1-328)-H in the
presence of 0.1% Triton X-100, showing that the presence of the
membrane anchor, a C-terminal His tag, and detergent did not affect
this bundling activity of ZipA (Fig. 4b). Very few solitary FtsZ
polymers were observed in these preparations, indicating that the bulk
of protofilaments were present in the bundles. Formation of bundles was
dependent on both FtsZ and GTP, since individual filaments, as well as
bundles, were completely absent in control samples in which FtsZ or
nucleotide was omitted or in which GTP was substituted with GDP (data
not shown). In contrast, bundles readily formed in reaction mixtures containing EDTA instead of Mg2+, demonstrating that the
interaction of ZipA with FtsZ polymers did not require the presence of
free divalent metals (Fig. 9C). Bundles also formed readily when FtsZ
and ZipA(23-328) were mixed before polymerization was induced by
addition of GTP, indicating that binding of ZipA to FtsZ does not
prevent the latter from polymerizing (data not shown). Most of our
polymerization and bundling assays were performed under slightly acidic
conditions (pH 5.8 to 6.0), which favor the formation of relatively
long and stable FtsZ polymers (22, 23). ZipA also induced
bundling at higher pH (6.5 and 7.0), but both the number and size of
the bundle networks we observed tended to be smaller (data not shown). Whether this is solely due to a less efficient formation of FtsZ protofilaments or whether ZipA-induced bundling itself is pH sensitive is currently not clear.
Domains required for bundling.
RayChaudhuri reported on the
bundling activity of ZipA during the course of this study and proposed
that ZipA is a MAP-Tau homolog, based on some homology between residues
45 to 70 of ZipA and a MAP-Tau repeat motif involved in the binding of
microtubule-associated proteins (MAPs) to microtubules (30).
To simultaneously test this proposal and delineate the protein domains
required for FtsZ polymer bundling, we next assayed the ability of
various other purified ZipA derivatives to induce bundling (Fig. 4B and
9).
Interestingly, the FZB domain proved to be not only required but
also sufficient for mediating the bundling of FtsZ polymers. Addition of purified T-ZipA(70-328),
Gfp-T-ZipA(186-328)-H, or T-ZipA(186-328)-H to FtsZ filaments in each case led to the formation of extensive bundle networks very similar to those described above (Fig. 4b and 9D). In contrast, ZipA(23-279), ZipA(1-302)-H, and Gfp-T-ZipA(212-328)-H all failed to induce bundling and also did not
appear to otherwise affect FtsZ protofilaments (Fig. 4b and 9E).
Since we defined the extreme C terminus of FtsZ as the domain which
interacts with the FZB domain of ZipA (see above), the latter should be
unable to bundle polymers of FtsZ derivatives that do not contain the C
terminus. To test this prediction, we used FtsZ(1-314)-H, in which aa
315 to 383 of native FtsZ were replaced with a His6 tag.
Upon incubation with GTP, this protein formed numerous protein
filaments, demonstrating that the C-terminal 69 residues of FtsZ are
not required for polymerization (Fig. 9F). Compared to filaments of the
native protein, the filaments of FtsZ(1-314)-H showed an increased
tendency to align, and most were present as thin bundles composed of
two to five filaments. Similar observations were made before with the
somewhat larger peptide FtsZ(1-320) (36). As shown in Fig.
9G, addition of ZipA(23-328) had no effect on the FtsZ(1-314)-H
polymers, showing that the C terminus of FtsZ is indeed required for
ZipA-mediated bundling of FtsZ filaments.
We conclude that the same domain we found to be required and sufficient
for binding of ZipA to FtsZ is also required and sufficient for
ZipA-mediated bundling of FtsZ polymers. It follows that residues 1 to
185, which include the MAP-Tau repeat-like motif (30), are
dispensable for both the FtsZ binding and bundling activities of ZipA.
Detection of FtsZ polymer bundles by fluorescence microscopy.
Since the size of the bundle networks we observed by EM was
significant, we reasoned that they should also be visible by light microscopy. We first tested this by using the Gfp-tagged ZipA derivative HT-ZipA(39-328)-Gfp. Consistent with the results above, this protein readily bound FtsZ on affinity blots (Fig. 4b) and partially accumulated at the septal ring in cells of strain PB103/pCH77 [wt/Plac::t-zipA(39-328)-gfp] (Fig. 6b).
As shown in Fig. 10A, addition of
purified HT-ZipA(39-328)-Gfp to preformed FtsZ polymers led to the
formation of large protein structures which could indeed be easily
visualized by fluorescence microscopy. Fluorescence was concentrated in
structures of variable shapes ranging from single thick rods to very
extensive networks of thinner filaments. When using FtsZ and
HT-ZipA(39-328)-Gfp at equimolar concentration (6.0 µM), we observed
very large and highly fluorescent networks which were difficult to
image in a single plane of focus. When we reduced the concentration of
the fluorescent protein to 0.6 µM, as was done for the experiments in
Fig. 10, numerous structures were still observed, but they tended to be
smaller and were subsequently easier to image in some detail. Analyses
of these structures by EM showed thick bundles of FtsZ polymers,
identical in appearance to the ones described above (Fig. 10B).
Formation of these structures, furthermore, was clearly dependent on
the presence of FtsZ polymers. In control experiments in which FtsZ
and/or GTP was omitted or in which GDP was substituted for GTP, the
fluorescence signal was largely homogenous. In addition, some
fluorescence was concentrated in what appeared as small vesicular
structures (Fig. 10C and D). Analyses by EM confirmed the absence of
FtsZ polymers and polymer bundles in these samples (data not
shown).

View larger version (121K):
[in this window]
[in a new window]
|
FIG. 10.
Detection of polymer bundles by fluorescence
microscopy. Purified native FtsZ (6.0 µM) was incubated in the
presence of GTP (1 mM) and Mg2+ (10 mM) at 30°C. After 5 min, purified H-T-ZipA(39-328)-Gfp was added to 0.6 µM. After an
additional 10 min, one sample was applied to a microscope slide and
observed immediately by fluorescence microscopy (A) and another was
used for observation by EM (B). The fluorescent samples shown in panels
C to F were prepared identically, except that GTP was replaced with GDP
(C), FtsZ was replaced with buffer (D), or H-T-ZipA(39-328)-Gfp was
replaced with either Gfp-T-ZipA(186-328)-H (E) or
Gfp-T-ZipA(212-328)-H (F). EM grids prepared from the reactions shown
in panels C to F showed extensive bundle networks as in panel A (E), no
bundles but many individual FtsZ protofilaments (F), or no individual
protofilaments or polymer bundles (C and D) (data not shown). Bar,
represents 0.1 µm (B) or 3.4 µm (A and C to F).
|
|
Addition of Gfp-T-ZipA(186-328), which essentially constitutes a
Gfp-tagged version of the minimal FZB domain, to FtsZ polymers produced
structures similar to those obtained with HT-ZipA(39-328)-Gfp (Fig.
10E). As expected, furthermore, Gfp-T-ZipA(212-328) failed to induce
FtsZ polymers to form visible networks (Fig. 10F). The results obtained
by fluorescence microscopy were thus fully consistent with those
obtained by EM (Fig. 9), indicating that analysis of ZipA-mediated
bundling of FtsZ filaments by fluorescence microscopy provides a valid
and convenient qualitative assay for FtsZ polymerization.
The membrane anchor of ZipA is required for function.
The
results above showed that the FZB domain of ZipA is sufficient and
required to bind and bundle FtsZ polymers in vitro and to associate
with the FtsZ ring in vivo. To test whether the FZB domain is also
sufficient to support cell division, we assessed the ability of various
deletion derivatives of ZipA to complement the division defect of cells
carrying a chromosomal zipA null allele. To this end, we
used the ZipA HID (heat-induced depletion) strain CH5/pCH32
[zipA::aph
recA::Tn10/repA(Ts) ftsZ+
zipA+] in which the chromosomal copy of
zipA is destroyed and ZipA is expressed from plasmid
pCH32. This plasmid is temperature sensitive for replication, such
that growth of these cells at 42°C results in depletion of ZipA
and a subsequent block in septation (11). CH5/pCH32 was
transformed with plasmids expressing various portions of ZipA under the
control of the lac promoter (Fig.
11), and the ability of transformants
to form colonies at 42°C in the presence of IPTG (at a wide range of
concentrations) was determined (Table 1).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 11.
Plasmids used to test correction of ZipA
by ZipA derivatives. (a) Inserts were cloned into the vector pMLB1113
such that expression of the proteins is under control of the
lac promoter and lacIq. See also the
legends to Fig. 1 and 6. (b) The ability of the plasmids to correct a
ZipA phenotype was determined as described in the text.
+, correction; , no correction. (c) Shown are the N-terminal domains
of ZipA, DjlA, and DjlA(1-32)-ZipA(23-328). Transmembrane segments as
predicted by the Dense Alignment Surface method (4)
(http://www.biokemi.su.se/~server/DAS/) are boxed. Residue numbers
are indicated in parentheses. The arrow marks the junction between DjlA
and ZipA residues in the DjlA-ZipA fusion.
|
|
Both pDB322 [Plac::zipA(1-328)], encoding
native ZipA, and pCH49
[Plac::zipA(1-328)-h], encoding
full-length ZipA fused to a C-terminal His tag, allowed colony
formation at 42°C with high efficiency (Table 1) and at low
concentrations of inducer (5 to 50 µM). At high concentrations of
inducer, pDB322 and pCH49 failed to support colony formation. This was
not unexpected, since we previously showed that overexpression of
native ZipA leads to a division block which can be relieved by
co-overexpression of FtsZ (10). Accordingly, when pDB322 or
pCH49 was introduced into wild-type strain PB103, cells formed
nonseptate filaments when grown in the presence of IPTG at
concentrations equal to or higher than 25 and 100 µM, respectively.
Quantitative immunoblotting, furthermore, showed that an increase of
ca. sixfold in the cellular concentration of either ZipA or ZipA-H is
sufficient to induce this division block (Table
2). In contrast, overexpression of the
ZipA(1-302)-H protein to this level had no effect on the division phenotype of PB103/pCH182 cells, consistent with a role for the FZB
domain in the division block caused by overexpression of full-length ZipA (Table 2). As shown in Table 1, plasmid pCH182 also failed to
support colony formation of ZipA
cells at any of the
inducer concentrations (0 to 500 µM), underscoring the notion that
the interaction between FZB and FtsZ is essential to ZipA function
(Table 1).
Although less toxic than native ZipA, overexpression of the
ZipA(23-328) protein in PB103/pCH79 cells to ~11-fold the normal level of ZipA still led to the formation of nonseptate filaments, showing that the membrane anchor is not required for the division block
(Table 2). Interestingly, however, plasmid pCH79
[Plac::zipA(23-328)] completely failed to
correct the ZipA
phenotype of CH5/pCH32 cells at 42°C
under any conditions, including those (<100 µM IPTG) under which the
levels of ZipA(23-328) (over)expression are too low to induce a
division block in wild-type cells (Table 1). Thus, although
ZipA(23-328) has an intact FZB domain which allows a significant
fraction of the protein to accumulate at the septal ring (Fig. 7C), the
protein does not support cell constriction.
This result implied that in addition to a functional FZB domain, the
membrane anchor is required for ZipA function. A comparison of the
distributions in PB103 cells of ZipA(23-328)-Gfp and
Gfp-T-ZipA(186-328) with that of ZipA(1-328)-Gfp (Fig. 7C, D, and A,
respectively) indicated that the presence of the membrane anchor in the
latter allows a more efficient localization to the septal ring, which is not unexpected since the anchor causes the protein to become concentrated at the membrane. [Note that the relatively high level of
cytoplasmic fluorescence observed in cells expressing ZipA(23-328)-Gfp and Gfp-T-ZipA(186-328) was not caused by cleavage of the fusions, since we detected no significant breakdown products in Western analyses
using both ZipA- and Gfp-specific antibodies (data not shown). It
seemed unlikely, however, that a more efficient localization alone
could explain the need for the anchor, because pCH79
[Plac::zipA(23-328)] failed to support
cell division in CH5/pCH32 cells even when significantly overexpressed
(Table 1). Other possibilities are that a precise orientation of ZipA
relative to the membrane and the FtsZ ring is required for full
function of the protein and the anchor is required to constrain this
orientation, or that the membrane anchor serves a more specific
essential function such as mediating interactions with other
septal-ring components.
To study these possibilities, we constructed plasmids
pCH172
[Plac::djlA(1-32)-zipA(23-328)]
and pCH174
[Plac::djlA(1-32)-zipA(23-328)-gfp] (Fig. 6 and 11). The former encodes a fusion protein in which the ZipA
membrane anchor is replaced with that of DjlA (MucZ), and the latter
encodes a Gfp-tagged version of this fusion. DjlA is an inner
membrane-associated DnaJ-like protein which, besides ZipA, is the only
other E. coli protein shown to insert in the membrane in the
unusual type lb (also designated as type III) topology, with a short
N-terminal domain that traverses the bilayer once (residues 1 to 32)
and the rest of the protein resident in the cytoplasm (3).
The predicted transmembrane domains of ZipA, DjlA, and the DjlA-ZipA
fusions are indicated in Fig. 11c. Expression of the DjlA-ZipA fusions
from pCH172 and pCH174 was relatively inefficient compared to
expression of native ZipA from pDB322. Since we detected no significant
breakdown products in Western analyses (data not shown), we suspect
that this is due to the poor translation initiation signal of the
djlA gene, which was retained in the djlA-zipA
fusion constructs. Even so, cell division appeared equally sensitive to
overexpression of DjlA-ZipA and native ZipA. Thus, when PB103/pCH172
cells were grown in the presence of 500 µM IPTG, the cellular level
of DjlA(1-23)-ZipA(23-328) was equal to ca. sixfold the normal level
of native ZipA, and cells formed nonseptate filaments (Table 2).
As shown in Fig. 7, fusion of the DjlA membrane anchor to
ZipA(23-328)-Gfp appeared to restore the ability of the protein to
efficiently associate with the septal ring. In fact, the distribution of fluorescence in PB103/pCH174 cells (Fig. 7F) appeared identical to
that in cells expressing ZipA(1-328)-Gfp (Fig. 7A), with virtually all
fluorescence being associated with the septal ring and very little
being present in the cytoplasm. This suggested that the DjlA portion of
the fusion indeed acted as a functional membrane anchor. Consistent
with this notion, we found that the bulk (>80%) of
DjlA(1-32)-ZipA(23-328) fractionated with insoluble material of
broken cells (data not shown) and that the bulk of fluorescent DjlA(1-32)-ZipA(23-328)-Gfp in FtsZ-depleted filaments of strain PB143/pDB346/pCH174 was distributed along the cell periphery (Fig. 8C).
Nevertheless, plasmid pCH172
[Plac::djlA(1-32)-zipA(23-328)] completely failed to support growth of CH5/pCH32 cells at 42°C at any
level of expression (Table 1).
To explore the possibility that ZipA(23-328) and/or
DjlA(1-32)-ZipA(23-328) might be capable of rescuing
ZipA
cells at a low temperature, we also introduced
pDB322, pCH79, and pCH172 into the